The management of blood glucose in a pregnant woman with type 1 diabetes is challenging, and the option of a glucose sensor or an insulin pump, both technologies recommended by current guidelines (3), may not be available for patients with either gestational or type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.